Acute liver failure associated with Garcinia cambogia use
Journal Title: Annals of Hepatology - Year 2016, Vol 15, Issue 1
Abstract
Millions of Americans regularly use herbal supplements, but many are unaware of the potential hidden dangers. Numerous supplements have been associated with hepatotoxicity and, indeed dietary/herbal supplements represent an increasingly common source of acute liver injury. We report a case of acute liver failure requiring liver transplantation associated with the use of Garcinia cambogia, a supplement widely promoted for weight loss. When patients present with acute hepatitis or liver failure from an unknown etiology, a careful history of supplement use should be performed.
Authors and Affiliations
Rebecca Corey, K. Werner, Andrew Singer, Adyr Moss, Maxwell Smith, Jessica Noelting, Jorge Rakela
Keywords
Related Articles
- EP ID EP78544
- DOI 10.5604/16652681.1184287
- Views 125
- Downloads 0
Hepatic Hydrothorax
Hepatic hydrothorax (HH) is a pleural effusion that develops in a patient with cirrhosis and portal hypertension in the absence of cardiopulmonary disease. Although the development of HH remains incompletely understood,...
IgG4-related sclerosing cholangitis
Economic growth leads to increase of obesity and associated hepatocellular carcinoma in developing countries
Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer and the third leading cause of cancer related death worldwide. In recent years, the prevalence of HCC has increased in both developing and d...
PGE2 induces MUC2 and MUC5AC expression in human intrahepatic biliary epithelial cells via EP4/p38MAPK activat
[b]Background[/b]. MUC2 and MUC5AC overproduction is considered to be associated with hepatolithiasis and related to inflammation. However, mechanisms underlying MUC upregulation under inflammatory stimulation in human i...
Relative Adrenal Insufficiency is Associated with the Clinical Outcome in Patients with Stable Decompensated Cirrhosis
Background. The clinical impact of relative adrenal insufficiency (AI) on patients with stable decompensated cirrhosis (DeCi) has not been yet elucidated. Aim. Explore the association between AI and outcome [death or liv...